483 Biocon Biologics India May 2018

483 Biocon Biologics India May 2018

Laura Fontan FDA$119.00 - Available Now

FDA investigators audited the Biocon Biologics India - Bengaluru, India facility and issued inspectional observations (via FDA 483) on 01 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 01 May 2018
  • Location: Bengaluru, India
  • FEI: 3003981475
Add To Cart